Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May guide myocarditis evaluation pending stronger data; leaves open prospective validation of cardiac MRI.
Myocarditis(Inflammation Of The Heart)It can result from multiple causes but most commonly attributed to infective agents that can injure the myocardium through direct invasion, production of cardiotoxic substances, or chronic inflammation with or without persistent infection.Myocarditis may present with a wide range of symptoms, ranging from mild dyspnea or chest pain that resolves without specific therapy to cardiogenic shock and death.Dilated cardiomyopathy with chronic heart failure is the major long-term sequela of myocarditis.Most often, myocarditis results from common viral infections; less commonly, specific forms of myocarditis may result from other pathogens, toxic or hypersensitivity drug reactions, giant-cell myocarditis, or sarcoidosis.The prognosis and treatment of myocarditis vary according to the cause, and clinical and hemodynamic data usually provide guidance to decide when to refer a patient to a specialist for endomyocardial biopsy.The aim of this review is to provide a practical and current approach to the evaluation and treatment of suspected myocarditis. DefinitionThe standard Dallas pathological criteria for the definition of myocarditis require that an inflammatory cellular infiltrate with or without associated myocyte necrosis be present on conventionally stained heart-tissue sections 1 .These criteria are limited by variability in interpretation, lack of prognostic value, and low sensitivity, in part due to sampling error 2,3 .These limitations have led to alternative pathological classifications with criteria that rely on cell-specific immunoperoxidase stains for surface antigens, such as anti-CD3, anti-CD4, anti-CD20, anti-CD68, and anti-human leukocyte antigen 4,5 .Criteria that are based on immunoperoxidase staining have greater sensitivity and may have prognostic value.6 Preliminary studies suggest that noninvasive cardiac magnetic resonance imaging (MRI) may provide an alternative method for diagnosis without the risks of biopsy.For example, regions of myocarditis are reported to correlate closely with regions of abnormal signal on cardiac MRI.7,8 The lack of consensus regarding the value of invasive studies such as endomyocardial biopsy and the overall good prognosis for patients with mild, acute dilated cardiomyopathy who have suspected myocarditis have led to recent recommendations that endomyocardial biopsy should be considered on the basis of the likelihood of finding specific treatable disorders. 9 Clinical Features And IncidenceAcute myocarditis is frequently first diagnosed as nonischemic dilated cardiomyopathy in a patient with symptoms that have been present for a few weeks to several months.However, manifestations range from subclinical disease to sudden death, with new-onset atrial or ventricular arrhythmias, complete heart block, or an acute myocardial infarction-like syndrome.Cardiac symptoms are variable and may include fatigue, decreased exercise tolerance, palpitations, precordial chest pain, and syncope.Chest pain in acute myocarditis can result from an associated pericarditis or, occasionally, from coronary-artery spasm.10
No takes yet. Share an insight, caveat, or question.
Prasad et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: